We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
-$18.3M
Cap. Flow
-$1.63B
Cap. Flow %
-5.69%
Top 10 Hldgs %
43.66%
Holding
291
New
10
Increased
60
Reduced
140
Closed
13

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$45.6M
2
AZN icon
AstraZeneca
AZN
+$37.9M
3
EOG icon
EOG Resources
EOG
+$23.4M
4
UNH icon
UnitedHealth
UNH
+$20.1M
5
LLY icon
Eli Lilly
LLY
+$14.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$152M
2
PG icon
Procter & Gamble
PG
+$129M
3
BNY
Bank of New York Mellon
BNY
+$128M
4
AAPL icon
Apple
AAPL
+$123M
5
CVX icon
Chevron
CVX
+$112M

Sector Composition

Rank Sector Weight
1 Technology 25.27%
2 Financials 17.16%
3 Consumer Staples 16.61%
4 Energy 11.67%
5 Healthcare 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLM icon
201
Martin Marietta Materials
MLM
$31.5B
$567K ﹤0.01%
1,228
-210
-15% -$82.8K
AON icon
202
Aon
AON
$76.5B
$566K ﹤0.01%
1,641
+233
+17% +$75.7K
CSL icon
203
Carlisle Companies
CSL
$14.3B
$559K ﹤0.01%
2,181
HAL icon
204
Halliburton
HAL
$26.9B
$559K ﹤0.01%
16,940
OGN icon
205
Organon & Co
OGN
$3.56B
$559K ﹤0.01%
26,841
-140,964
-84% -$3.06M
WFC icon
206
Wells Fargo
WFC
$261B
$509K ﹤0.01%
11,929
-2,926
-20% -$118K
AZO icon
207
AutoZone
AZO
$49.2B
$499K ﹤0.01%
200
IHG icon
208
InterContinental Hotels
IHG
$23.9B
$498K ﹤0.01%
7,065
T icon
209
AT&T
T
$159B
$493K ﹤0.01%
30,927
-1,061
-3% -$18.1K
HUM icon
210
Humana
HUM
$43.7B
$492K ﹤0.01%
1,100
+300
+38% +$151K
ECL icon
211
Ecolab
ECL
$78.1B
$481K ﹤0.01%
2,578
+829
+47% +$143K
PB icon
212
Prosperity Bancshares
PB
$8.97B
$471K ﹤0.01%
8,338
STEL
213
DELISTED
Stellar Bancorp
STEL
$464K ﹤0.01%
20,263
CR icon
214
Crane Co
CR
$12.3B
$454K ﹤0.01%
+5,099
New +$394K
EXP icon
215
Eagle Materials
EXP
$6.29B
$452K ﹤0.01%
2,425
MCO icon
216
Moody's
MCO
$82.8B
$447K ﹤0.01%
1,285
GEHC icon
217
GE HealthCare
GEHC
$30.7B
$446K ﹤0.01%
5,495
+117
+2% +$9.34K
SEIC icon
218
SEI Investments
SEIC
$12.4B
$435K ﹤0.01%
7,300
SPYV icon
219
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
$421K ﹤0.01%
+9,751
New +$403K
CFR icon
220
Cullen/Frost Bankers
CFR
$10.3B
$421K ﹤0.01%
3,914
-725
-16% -$75.7K
XIFR
221
XPLR Infrastructure LP
XIFR
$1.12B
$399K ﹤0.01%
6,804
-5,671
-45% -$341K
VZ icon
222
Verizon
VZ
$195B
$390K ﹤0.01%
10,500
-1,219
-10% -$45.1K
OXY icon
223
Occidental Petroleum
OXY
$56.8B
$389K ﹤0.01%
6,624
+1,173
+22% +$70.4K
MSI icon
224
Motorola Solutions
MSI
$72.3B
$370K ﹤0.01%
1,262
+54
+4% +$15.5K
ORLY icon
225
O'Reilly Automotive
ORLY
$72.9B
$358K ﹤0.01%
+5,625
New +$343K

Similar funds

Fayez Sarofim & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, down 0.06% from $28.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co withdrew a net $1.63B in Q2 2023, closing 13 positions and reducing 140 holdings. Its most notable exit was AvalonBay Communities, an estimated $1.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Fayez Sarofim & Co opened a new position in iShares Core High Dividend ETF worth $8.67M.

  • Fayez Sarofim & Co's largest Q2 2023 buy was iShares Core High Dividend ETF: 430,000 shares worth $8.67M.
  • Fayez Sarofim & Co added most to CME Group in Q2 2023, an estimated $45.6M increase.
  • Fayez Sarofim & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $152M.
  • Fayez Sarofim & Co fully exited AvalonBay Communities in Q2 2023, selling an estimated $1.33M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $28.6B portfolio in Q2 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 13 in Q2 2023.
  • Fayez Sarofim & Co's portfolio value fell 0.06% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2023, filed 14 Aug 2023.